LOS ANGELES, March 29, 2018 -- US based company Earth Healthcare offers a new Cannabis DNA Test Kit. Earth Healthcare's patent-pending Cannabis test kit, CANNA DNA Test Kit allows Earth Healthcare labs to analyze your genetic markers to determine your body's natural inclination to accept cannabinoids as medicine - whether the cannabinoids are produced endogenously, from plants or synthetically. This approach takes the guesswork out of medical cannabis use, offering you personalized treatment options that will optimize efficacy and minimize unintended effects.
|
|||||
We all have a different DNA makeup; our DNA proves it. That is why our body processes everything its own individual way, including cannabis. Would you like to know what your DNA says about how your body will react when you use cannabis?
Cannabinoids are such a useful and unique medicine to help restore homeostasis in the body because it is cannabinoids that are naturally produced in the body (endogenously) that we rely on for homeostasis. As a result, many imbalances and ailments can be restored from the use of exogenous cannabinoids, produced outside the body.
With the rise in medical cannabis use for a variety of medical conditions including cancer, autoimmune disorders, and dietary issues, Earth Healthcare's CANNA DNA genetic test kit will allow people to know how their body will react to it. This approach will take the guesswork out of cannabis use, offering personalized treatment recommendations that optimize efficacy and minimize unintended effects.
CANNA DNA Test Kit can target symptom relief, and the results can be customized for patients with symptom-relief recommendations specifically in the areas of Anxiety, Appetite, Stress, Insomnia, Nausea, and Pain.
Earth Healthcare's kits are available online at EarthHealthcare.com, dispensaries, and physicians offices. The kits include; sample-collection swabs, instructions, and a pre-addressed, stamped envelope. The samples are mailed to Earth Healthcare's CLIA-accredited and CAP-certified partner laboratory, where they analyze your DNA and compile a customized report. The report includes a cannabis-specific genomic profile, identifying how your body metabolizes Delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), and recommendations of cannabis varieties best suited to your body chemistry and specific needs.
Scientific research continues to validate its efficacy for an expanding spectrum of illnesses and conditions. Yet, doctors have been limited to recommending cannabis without having supportive data to allow them to prescribe the medicine safely and effectively, until now.
Visit Earth Healthcare's Website to get more information or to order a kit at: www.earthhealthcare.com
Company: Earth Healthcare
Media Contact: Nicole Lenz
Los Angeles, CA
[email protected]
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/92addbb0-047c-4121-9e13-31f0f70c1b84


CIA-Linked Investor Helped Quantum Systems Expand in US
Trump Secures Drug Pricing Deals With Nine Pharma Companies
Jefferies Names AMEC Top China Semiconductor Equipment Pick
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
Toyota Global Sales Fall as China Demand Slumps
Faraday Future Delivers First Robots in Middle East, Plans September Launches
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
OpenAI AI Agent Swarm Behind Hugging Face Hack
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return
Star Entertainment Shares Fall After A$307 Million FY2026 Loss
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 



